Enzon Reports Solid Second Quarter 2008 Results - Enzon Pharmaceuticals, Inc.(Nasdaq: ENZN) today announced solid second quarter 2008 financial results.
For the three months ended June 30, 2008, Enzon reported a net loss of $1.7 million or $0.04 on a diluted per-share basis, as...
Enzon Reports Solid Second Quarter 2008 Results BRIDGEWATER, N.J.--(BUSINESS WIRE<http://www.businesswire.com>)-- Enzon Pharmaceuticals, Inc.(Nasdaq: ENZN) today announced solid second quarter 2008 financial results.
For the three months ended June 30, 2008, Enzon...
Enzon Reports Solid Second Quarter 2008 Results BRIDGEWATER, N.J.--(BUSINESS WIRE)--Enzon Pharmaceuticals, Inc.(Nasdaq: ENZN - News) today announced solid second quarter 2008 financial results.
For the three months ended June 30, 2008, Enzon reported a net loss of $1.7 million or $0...
Financial Report: Enzon 2Q @ 09:42 am 2Q Loss: $1.7 million (loss of $2.0 million in 2Q07) Comments: Contract manufacturing revenue was $6.7 million in the quarter, up 14% due to deliverables.The company warned that it likely will not maintain contract revenues at...
Enzon Files for Spin-off of Biotech Business BRIDGEWATER, N.J.--(BUSINESS WIRE)--Enzon Pharmaceuticals, Inc.(Nasdaq: ENZN - News) announced today that it filed a Form 10 Registration Statement with the U.S.
Securities and Exchange Commission (SEC) related to its previously...
Enzon Files for Spin-off of Biotech Business Enzon Pharmaceuticals Inc (ENZN) Stock Quote, Chart, News, Add to Watchlist Enzon Pharmaceuticals, Inc.ENZN announced today that it filed a Form 10 Registration Statement with the U.S.
Securities and Exchange Commission (SEC) related to...
Enzon Files for Spin-off of Biotech Business BRIDGEWATER, N.J.--(BUSINESS WIRE)--Enzon Pharmaceuticals, Inc.(Nasdaq: ENZN - News) announced today that it filed a Form 10 Registration Statement with the U.S.
Securities and Exchange Commission (SEC) related to its previously...
Enzon Files for Spin-off of Biotech Business (BUSINESS WIRE) -- Enzon Pharmaceuticals, Inc.(ENZN: ENZN News, chart, profile, more Last: Delayed quote data Add to portfolio Analyst Create alert Insider Discuss Financials Sponsored by: , , ) announced today that it filed a Form 10...
Enzon Pharmaceuticals, Inc. - SWOT Analysis - New Research Report on Companies and Markets Company-Profile/Enzon-Pharma ..Enzon Pharmaceuticals, Inc.
SWOT company profile is the essential source for top-level company data and information.
The report examines the company's key business structure and operations, history and...
Jack Geltosky, Ph.D. Joins Enzon's Board of Directors BRIDGEWATER, N.J.--(BUSINESS WIRE)--Enzon Pharmaceuticals, Inc.(Nasdaq: ENZN - News) today announced that Dr.
Jack Geltosky has been appointed to the Company's Board of Directors.
" BRIDGEWATER, N.J.--(BUSINESS WIRE)--Enzon...
Enzon Stockholders Approve Company Proposals at 2008 Annual Meeting -- Re-electing Rolf A.Classon, Robert LeBuhn and Robert C.
Salisbury as Class III directors to serve for a term of three years until the 2011 Annual Meeting and until their successors are elected and qualified; and -- Ratifying the...
